Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma-Reference-Cited by-同舟云学术

Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma

Published:2013-12-17 Issue:12 Volume:8 Page:e82742
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Budde Lihua E.,Berger Carolina,Lin Yukang,Wang Jinjuan,Lin Xubin,Frayo Shani E.,Brouns Shaunda A.,Spencer David M.,Till Brian G.,Jensen Michael C.,Riddell Stanley R.,Press Oliver W.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Cancer statistics, 2012;R Siegel;CA Cancer J Clin,2012

2. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias;RJ Brentjens;Blood,2011

3. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia;DL Porter;N Engl J Med,2011

4. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia;M Kalos;Science Translational Medicine,2011

5. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells;JN Kochenderfer;Blood,2012

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting CD45 by gene-edited CAR T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioning;Molecular Therapy: Oncology;2024-09

2. A New Chimeric Antibody against the HIV-1 Fusion Inhibitory Peptide MT-C34 with a High Affinity and Fc-Mediated Cellular Cytotoxicity;Biology;2024-08-29

3. iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine;BioEssays;2024-06-25

4. Immunotherapeutic Strategies Targeting Breast Cancer Stem Cells;Current Oncology;2024-05-29

5. Strategies for modifying the chimeric antigen receptor (CAR) to improve safety and reduce toxicity in CAR T cell therapy for cancer;International Immunopharmacology;2023-12